ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 419281 | Rec_0431939 | VEGFR2-Lytic |
ATWLPPRGGGKLLLKLLKKLLKLLKKK |
synthetic construct [Synthetic] |
Anticancer, Cytotoxic |
BxPC-3 |
12.2 μM | IC50 |
- | US 2011/0319336 A1; EP2370107A2 |
YES |
| 419282 | Rec_0431940 | VEGFR2-Lytic |
ATWLPPRGGGKLLLKLLKKLLKLLKKK |
synthetic construct [Synthetic] |
Anticancer, Cytotoxic |
U937 |
3.5 μM | IC50 |
- | US 2011/0319336 A1; EP2370107A2 |
YES |
| 419283 | Rec_0431941 | VEGFR2-Lytic |
ATWLPPRGGGKLLLKLLKKLLKLLKKK |
synthetic construct [Synthetic] |
Anticancer, Cytotoxic |
LNCaP |
8.9 μM | IC50 |
- | US 2011/0319336 A1; EP2370107A2 |
YES |
| 419284 | Rec_0431942 | VEGFR2-Lytic |
ATWLPPRGGGKLLLKLLKKLLKLLKKK |
synthetic construct [Synthetic] |
Cytotoxicity assessment |
HEK293 |
>20 μM | IC50 |
- | US 2011/0319336 A1; EP2370107A2 |
YES |
| 419285 | Rec_0431943 | VEGFR2-Lytic |
ATWLPPRGGGKLLLKLLKKLLKLLKKK |
synthetic construct [Synthetic] |
Cytotoxicity assessment |
MRC-5 |
>20 μM | IC50 |
- | US 2011/0319336 A1; EP2370107A2 |
YES |
| 419286 | Rec_0431944 | Ala-Tyr-Ile (AYI) |
AYI |
not reported [other] |
Antioxidant |
- |
0.90 μmol TE/μmol peptide | ABTS radical scavenging assay |
- | - |
YES |
| 419287 | Rec_0431945 | Ala-Tyr-Ile (AYI) |
AYI |
not reported [other] |
Antioxidant |
- |
1.37 μmol TE/μmol peptide | ORAC |
- | - |
YES |
| 419288 | Rec_0431946 | Atacicept |
AMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLRSEPKSSDKTHTCPPCPAPEAEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPSSIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK |
synthetic construct [Synthetic] |
Immunomodulatory, BAFF/APRIL neutralization |
BLyS (BAFF); APRIL; BLyS/APRIL heterotrimer; TACI-transfected Jurkat cells; primary human B cells |
- | TACI-Jurkat signaling assay; primary human B-cell proliferation/neutralization assay |
20302641 | - |
YES |
| 419289 | Rec_0431947 | Atacicept |
AMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLRSEPKSSDKTHTCPPCPAPEAEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPSSIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK |
synthetic construct [Synthetic] |
Anticancer, Growth inhibition, Immunomodulatory |
TACI-high primary myeloma cells; SCID-hu myeloma model |
- | SCID-hu in vivo tumor-growth assay; osteoclast coculture MTT growth-inhibition assay |
18046446 | - |
YES |
| 419290 | Rec_0431948 | HH234 |
ILWWKWPWWPWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa strain H1001 (fliC::luxCDABE) |
- | lux-based antimicrobial killing assay (complete indolicidin substitution analysis) |
- | US 9017656 B2 |
YES |
| 419291 | Rec_0431949 | PLP180-199 |
WTTCGSIAFPSKTSASIGSL |
synthetic construct [Synthetic] |
Immunomodulatory, Encephalitogenic antigen |
Mus musculus experimental autoimmune encephalomyelitis (EAE) model; PLP180-199-specific T cells |
- | PLP180-199 immunization/EAE induction; peptide-specific T-cell cytokine/proliferation assay |
21674475 | - |
YES |
| 419292 | Rec_0431950 | Bac203 |
DLARIVVIRVAR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa strain H1001 (fliC::luxCDABE) |
- | lux-based antimicrobial killing assay (complete Bac2A substitution analysis) |
- | US 2008/0207522 A1 |
YES |
| 419293 | Rec_0431951 | SHP pheromone (EIIIIVGG) |
EIIIIVGG |
Streptococcus pyogenes [Bacterium] |
Cell-Cell Communication, Quorum Sensing, Pheromone signaling |
Streptococcus pyogenes Rgg2/Rgg3 quorum-sensing system |
- | synthetic pheromone stimulation; transcriptional reporter/gene-expression assay; biofilm assay |
21829369 | - |
YES |
| 419294 | Rec_0431952 | Myosuppressin |
TDVDHVFLRF |
Drosophila melanogaster [Animal] |
Neuropeptide, Myoinhibitory peptide, Receptor agonist |
Drosophila melanogaster myosuppressin receptors DMSR-1/DMSR-2 (CHO expression system) |
40 nM | EC50 receptor activation assay |
12907701 | - |
YES |
| 419295 | Rec_0431953 | Urotoxin (α-KTx 6.21) |
GDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCV |
Urodacus yaschenkoi [Animal] |
Potassium channel blocker; Ion channel inhibitor; Toxin |
human Kv1.1 potassium channel |
253 nM | IC50 |
24723491 | - |
YES |
| 419296 | Rec_0431954 | Urotoxin (α-KTx 6.21) |
GDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCV |
Urodacus yaschenkoi [Animal] |
Potassium channel blocker; Ion channel inhibitor; Toxin |
human Kv1.3 potassium channel |
91 nM | IC50 |
24723491 | - |
YES |
| 419297 | Rec_0431955 | Urotoxin (α-KTx 6.21) |
GDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCV |
Urodacus yaschenkoi [Animal] |
Potassium channel blocker; Ion channel inhibitor; Toxin |
human KCa3.1 potassium channel |
70 nM | IC50 |
24723491 | - |
YES |
| 419298 | Rec_0431956 | Urotoxin (α-KTx 6.21) |
GDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCV |
Urodacus yaschenkoi [Animal] |
Potassium channel blocker; Ion channel inhibitor; Toxin |
human Kv1.1 potassium channel |
468 nM | Kd |
24723491 | - |
YES |
| 419299 | Rec_0431957 | Urotoxin (α-KTx 6.21) |
GDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCV |
Urodacus yaschenkoi [Animal] |
Potassium channel blocker; Ion channel inhibitor; Toxin |
human Kv1.2 potassium channel |
190 pM | Kd |
24723491 | - |
YES |
| 419300 | Rec_0431958 | Urotoxin (α-KTx 6.21) |
GDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCV |
Urodacus yaschenkoi [Animal] |
Potassium channel blocker; Ion channel inhibitor; Toxin |
human KCa3.1 potassium channel |
109 nM | Kd |
24723491 | - |
YES |